We bring you the latest news from the healthcare about the health care in the United Kingdom. Do your have news for us? Contact the editor. Watch also this special movie.

donderdag 27 juli 2017

Latest content from npj Breast Cancer: 27 July 2017

If you are unable to see the message below, click here to view.
npj Breast Cancer

Advertisement
An online-only, open access, multidisciplinary journal dedicated to publishing high-quality original research articles, reviews, editorials, commentaries, and hypothesis generating observations on all areas of breast cancer research. Part of the Nature Partner Journals series, published in partnership with the Breast Cancer Research Foundation. 

Now open for submissions >> 

Table of Contents: July 2017

Perspective | 20 July 2017

CREATE-X a role for capecitabine in early-stage breast cancer: an analysis of available data

Jo Anne Zujewski & Lawrence Rubinstein

npj Breast Cancer 3, Article number: 27 | doi:10.1038/s41523-017-0029-3

Article | 17 July 2017

Metabolic reprogramming underlies metastatic potential in an obesity-responsive murine model of metastatic triple negative breast cancer

Ciara H. O'Flanagan, Emily L. Rossi, Shannon B. McDonell, Xuewen Chen, Yi-Hsuan Tsai et al.

npj Breast Cancer 3, Article number: 26 | doi:10.1038/s41523-017-0027-5

Article | 10 July 2017

Human snoRNA-93 is processed into a microRNA-like RNA that promotes breast cancer cell invasion

Dillon G. Patterson, Justin T. Roberts, Valeria M. King, Dominika Houserova, Emmaline C. Barnhill et al.

npj Breast Cancer 3, Article number: 25 | doi:10.1038/s41523-017-0032-8

Article | 03 July 2017

Next-generation sequencing of circulating tumor DNA to predict recurrence in triple-negative breast cancer patients with residual disease after neoadjuvant chemotherapy

Yu-Hsiang Chen, Bradley A. Hancock, Jeffrey P. Solzak, Dumitru Brinza, Charles Scafe et al.

npj Breast Cancer 3, Article number: 24 | doi:10.1038/s41523-017-0028-4

Your email address is in the npj Breast Cancer mailing list.
You have been sent this alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: myaccount (You will need to log in to be recognised as a nature.com registrant)
For further technical assistance, please contact our registration department
For print subscription enquiries, please contact our subscription department
For other enquiries, please contact our customer feedback department
Springer Nature | One New York Plaza, Suite 4500 | New York | NY 10004-1562 | USA
Springer Nature's worldwide offices:
London - Paris - Munich - New Delhi - Tokyo - Melbourne
San Diego - San Francisco - Washington - New York - Boston
Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at The Campus, 4 Crinan Street, London, N1 9XW.
© 2017 Macmillan Publishers Limited, part of Springer Nature. All rights reserved.
Springer Nature